急性心肌梗死经皮冠状动脉介入治疗后非梗死相关动脉病变进展的临床研究现状  

Disease Progress of Non-infarcted Related Artery in Patients with Acute ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention

作　　者：盛博[1] 陈炜[1] 

机构地区：[1]首都医科大学附属北京世纪坛医院重症医学科,北京100038

出　　处：《医学综述》2017年第6期1141-1145,共5页Medical Recapitulate

摘　　要：随着经皮冠状动脉介入(PCI)技术的日益成熟,极大地挽救了濒死心肌,降低了恶性心血管事件的发生率,从而改善急性心肌梗死患者的预后。直接PCI治疗在急诊胸痛中的应用越来越广泛,其临床疗效的评价已引起越来越多介入心脏医师的重视。急性ST段抬高型心肌梗死(STEMI)患者中由于较多患者存在多支血管病变,使其成为高病死率的危险亚群。直接PCI可以改善梗死相关动脉(IRA)的血流灌注,最大程度地缩小心肌梗死面积。但直接PCI术干预IRA后可能加速非IRA病变进展,而非IRA病变进展可能对急性STEMI患者直接PCI术后预后产生重要影响。The substantial mature of percutaneous coronary intervention（PCI） technology greatly saves the dying myocardium,reduces the occurrence of malignant cardiovascular events,thereby improves the prognosis of patients with acute myocardial infarction. A number of interventional cardiac treatment doctors began to pay more and more attention about how to evaluate the clinical curative effect of this technology. Studies have showed that multiple significant coronary lesions exist in patients presenting with acute coronary syndromes,particularly ST-segment elevation myocardial infarction（STEMI）. It has become a dangerous subgroup of high mortality. Direct PCI can improve blood perfusion of infarction related artery（IRA） and it reduces myocardial infarction size extremely. However,the direct PCI after IRA may accelerate the progression of non-IRA lesions,which may have a great impact on the prognosis of patients with acute STEMI after direct PCI.

关 键 词：急性ST段抬高型心肌梗死 直接经皮冠状动脉介入 非梗死相关动脉 

分 类 号：R543.31[医药卫生—心血管疾病]